Cosmos Holdings, a publicly traded company, recently announced its first-quarter results, revealing a net income of $12.5 million and a…
Browsing: research and development
Ascent Industries, a prominent player in medical cannabis research, production, and distribution, has recently made headlines with its latest financial…
Roche’s Alzheimer’s drug Gantenerumab has experienced a major setback. It failed phase 3 clinical trials, resulting in financial losses for…
ECARX, a Chinese EV tech developer, witnessed a staggering 170% surge in its stock value. Cementing its position in the…
MorphoSys is on track to complete its Phase 3 myelofibrosis program 16% faster than originally planned. [1] However, there is…
MorphoSys, a German biopharmaceutical company, has reported its fourth-quarter financial results, showing signs of improvement and reaffirming its guidance for…